tirzepatide taper schedule Dosing Weight Loss Blog – Maryland

This reduces the risk of potential side effects

Gut health (BPC-157): Early studies suggest potential for protecting or repairing the digestive tract, which appeals to women with IBS, food sensitivities, or gut inflammation

When to Consider Switching to Compounded Semaglutide or Alternative GLP-1 Options If you struggle with rebound appetite during tapering, or if your weight loss stalls prematurely, continuing GLP-1 therapy at a lower maintenance dose may be more effective than stopping entirely

Semaglutide trials raised attention to retinopathy complications in certain contexts, likely concentrated in people with pre-existing eye disease and large HbA1c drops

doi: 10.1007/s00401-010-0749-z 58 SolomouGDulanka SilvaAHWongAPohlUTzerakisN

FDA under the brand Zepbound in November 2023, and by European regulators as Mounjaro in June 2024